Two Sigma Securities’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,372
Closed -$307K 1990
2025
Q1
$307K Buy
+1,372
New +$320K 0.05% 575
2023
Q4
Sell
-3,400
Closed -$522K 3495
2023
Q3
$503K Buy
3,400
+787
+30% +$142K 0.01% 1537
2023
Q2
$571K Buy
+2,613
New +$582K 0.01% 1344
2023
Q1
Sell
-3,377
Closed -$733K 3165
2022
Q4
$703K Buy
3,377
+1,578
+88% +$347K 0.02% 874
2022
Q3
$393K Buy
1,799
+582
+48% +$132K 0.01% 1317
2022
Q2
$255K Buy
+1,217
New +$259K 0.01% 1453
2022
Q1
Sell
-1,794
Closed -$467K 2439
2021
Q4
$467K Buy
1,794
+698
+64% +$181K 0.02% 561
2021
Q3
$289K Buy
+1,096
New +$300K 0.01% 1020
2021
Q1
Sell
-1,839
Closed -$391K 1584
2020
Q4
$391K Sell
1,839
-65
-3% -$13K 0.01% 850
2020
Q3
$326K Buy
+1,904
New +$352K 0.01% 810
2020
Q1
Sell
-1,981
Closed -$307K 2142
2019
Q4
$307K Sell
1,981
-992
-33% -$143K ﹤0.01% 1776
2019
Q3
$402K Sell
2,973
-1,598
-35% -$209K ﹤0.01% 1348
2019
Q2
$558K Buy
4,571
+535
+13% +$59.3K 0.01% 1051
2019
Q1
$420K Buy
+4,036
New +$417K ﹤0.01% 974
2018
Q3
Sell
-4,184
Closed -$458K 2939
2018
Q2
$433K Buy
+4,184
New +$423K ﹤0.01% 1830

Other funds holding RMD

Two Sigma Securities's RMD Position: Q2 2025 in Review

Two Sigma Securities sold out of ResMed (RMD) in Q2 2025, closing a stake of 1,372 shares — an estimated $307K sold.

Two Sigma Securities first reported a position in RMD in Q2 2018 and held it in 15 quarters. The position peaked at $703K in Q4 2022. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

  • Two Sigma Securities reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Securities sold 1,372 ResMed shares in Q2 2025, an estimated $307K.
  • Two Sigma Securities first reported a position in ResMed in Q2 2018 and held it in 15 quarters.
  • Two Sigma Securities's ResMed position peaked at $703K in Q4 2022.
  • 919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.